BBC News chief presenter Maryam Moshiri spent months anchoring global broadcasts while quietly undergoing grueling medical treatments for a rare, chronic form of blood cancer known as polycythaemia vera. Diagnosed in November 2024, Moshiri’s public disclosure brings a vital spotlight onto the realities of living with a hidden, lifelong malignancy that lacks a cure but demands relentless management.
Polycythaemia vera (PV) operates quietly inside the bone marrow, forcing the body to churn out an excessive volume of red blood cells. This overproduction changes the physical property of the fluid itself, making the blood significantly thicker than normal. That viscosity increases the threat of dangerous clots, strokes, and cardiovascular emergencies. For Moshiri, the diagnosis arrived without warning symptoms. A fastidious general practitioner caught the anomaly during routine blood work, sending her straight down a path of medical intervention that most viewers sitting across from their television screens never suspected.
The physical toll of early treatment required aggressive measures. Moshiri underwent a series of venesections, clinical procedures where needles are inserted into arm veins to draw out units of blood and reduce overall cell concentration. Repeated roughly eight times over a short span, these sessions stripped her iron stores to minimal levels.
Exhaustion settled in deeply. She experienced severe hair loss, widespread skin irritation, and a chronic fatigue that felt as though someone had physically unplugged her energy. Live television demands an immediate spike of adrenaline and intense mental clarity, forcing anchors to maintain high performance under immense pressure. Behind the studio lights, however, the reality involved returning home to collapse on the sofa for hours of recovery.
Medical management eventually shifted toward immunotherapy via weekly interferon injections. While this transition reduced the frequency of blood-letting procedures, the secondary effects of the medication brought their own hurdles, including severe headaches, insomnia, and intense itching severe enough to cause skin damage.
Blood cancer charities emphasize that Moshiri’s experience reflects a broader societal misconception. Public perception often frames cancer strictly through a binary lens of acute chemotherapy followed by complete remission, ignoring the category of chronic blood malignancies where patients live indefinitely under medical surveillance, treatment schedules, and symptom management.
By bringing attention to Blood Cancer UK's campaigns, Moshiri aims to highlight the hidden milestones and missed moments that patients endure while balancing grueling therapies with everyday responsibilities. She continues to anchor major international events, demonstrating that professional longevity can coexist with a chronic diagnosis, provided the medical regimen is tailored to keep the disease under control.
